Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
Apple bought Tueo Health, which was developing tech to help parents monitor asthma symptoms in children, using a mobile app and commercial breathing sensors.Technologyread more
United Airlines will take its 14 Boeing 737 Max jets off its schedule for another month, through Aug. 3, canceling another 1,290 flights.Airlinesread more
Trade could be a big factor for markets in the week ahead, but investors will also be attuned to fresh inflation data and the bond market, which is flashing new worries about...Market Insiderread more
The Mississippi law is one among a number of states that have moved to pass new restrictions on abortion this year.Politicsread more
About three dozen House Democrats have called for impeachment hearings on President Donald Trump, a billionaire's TV ads rip the House for "doing nothing," and legal experts...Politicsread more
CVS Health Corp.: "Here's what I've been telling club members of ActionAlertsPlus.com, which follows along with my charitable trust: I think CVS is one of the absolute cheapest stocks, now that it's bought Aetna, in the country, and [CEO] Larry Merlo should come on air and tell us about it. "
Neogenomics Inc.: "Cancer genetics is a very, very big, great, speculative area. We saw that from Loxo Oncology when [Eli] Lilly bought that company. I am not going to say that you can't speculate on that. I am brazen. "
Vicor Corp.: "No. Power systems I regard as a commodity. I've looked at the company over and over again. I'm going to say don't buy."
T. Rowe Price Group: "A lot of people have turned a lot on all of these stocks that have to do with equities, picking equities. This yields 3 percent. It's a very well-run company. I'm not going to tell you to go away from it. I'm going to tell you to go toward it."
The Clorox Co.: "You are paying a high multiple for Clorox. One of my themes this week and last week was the high multiple you're paying for safety. I like Clorox. I regard it as the best of the consumer packaged goods. But always remember it is an expensive stock, and I'd prefer to get it at maybe a 3 percent yield instead of 2.6. But [CEO] Benno Dorer is doing terrific."